Elucigene QST*R

Elucigene QST*R kits are a range of DNA based multiplexed diagnostic assays that use STR markers to detect the three most common viable autosomal trisomies: trisomy 21 (Down syndrome), trisomy 18 (Edwards syndrome) and trisomy 13 (Patau syndrome). Additional markers on the sex chromosomes X and Y can detect the most common sex chromosome aneuploidies, Klinefelter syndrome and Turner syndrome.

The QST*R series of rapid DNA test kits — fully validated for in vitro diagnostic use and suitable for both chorionic villus and amniotic fluid analysis — makes the powerful QF-PCR technique widely available for routine use in molecular cytogenetic procedures.

Elucigene QST*R provides

a simple one tube, highly multiplexed, PCR assay - minimal transfer steps
reagents ready mixed - just add DNA
markers informative in more than 99% of analyses
a rapid test - can provide a definitive result within 4 hours, including DNA extraction
customised analysis and reporting software
a test which is validated for use on Applied Biosystems' 3100/3130 Genetic Analyzers
a test developed in collaboration with Guy’s and St Thomas’ Hospital, London
a test which is compliant with the requirements of IVDD directive 98/79/EC and manufactured to ISO 9001:2000/ISO13485:2003

For more information on the Elucigene QST*R products please go to the downloads section.

All QST*R kits comply with the EC Directive 98/79/CE, carry the CE mark and are manufactured within quality systems accredited to ISO9001:2000 and ISO13485. Full technical support is provided to purchasers of kits to ensure acceptable performance and customer satisfaction.

Elucigene QST*R products are not available for sale in the United States